Unknown

Dataset Information

Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3.


ABSTRACT:

Background

Breast cancer (BC) is a common malignancy with highly female incidence. So far the function of notoginsenoside R1 (NGR1), the extract from Panax notoginseng, has not been clearly elucidated in BC.

Methods

Optimal culture concentration and time of NGR1 were investigated by cell counting kit-8 assay. Cell proliferation ability was measured by colony formation assays. Transwell assay was used to detect the effect of NGR1 on cell migration and invasion. The apoptosis rate of cells between each group was measured by TUNEL assay.

Results

NGR1 treatment has an inhibitory effect on proliferation, migration, invasion, and angiogenesis and a stimulating effect on cell cycle arrest and apoptosis of Michigan Cancer Foundation-7 (MCF-7) cells. The 50% growth inhibitory

SUBMITTER: Qin HL 

PROVIDER: S-EPMC7929486 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature